HMGA2 induces pituitary tumorigenesis by enhancing E2F1 activity

Cancer Cell

Volumn 9, Issue 6, 2006, Pages 459-471

  Fedele, Monica ^a   Visone, Rosa ^a,b   De Martino, Ivana ^a   Troncone, Giancarlo ^c   Palmieri, Dario ^a   Battista, Sabrina ^a   Ciarmiello, Andrea ^d   Pallante, Pierlorenzo ^a   Arra, Claudio ^d   Melillo, Rosa Marina ^a   Helin, Kristian ^e,f   Croce, Carlo Maria ^b   Fusco, Alfredo ^a  

^a CNR   (Italy)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

CELLCYCLE

Indexed keywords

HIGH MOBILITY GROUP A2 PROTEIN; RETINOBLASTOMA PROTEIN; TRANSCRIPTION FACTOR E2F1;

ACETYLATION; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; EMBRYO; FETUS; HUMAN; HUMAN CELL; HYPOPHYSIS ADENOMA; MATING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; RAT;

MUS MUSCULUS;

EID: 33744808027     PISSN: 15356108     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ccr.2006.04.024     Document Type: Article

References (27)

1. Asa S.L., and Ezzat S. The pathogenesis of pituitary tumours. Nat. Rev. Cancer 2 (2002) 836-849
2. Baldassarre G., Fedele M., Battista S., Vecchione A., Klein-Szanto A.J., Santoro M., Waldmann T.A., Azimi N., Croce C.M., and Fusco A. Onset of natural killer cell lymphomas in transgenic mice carrying a truncated HMGI-C gene by the chronic stimulation of the IL-2 and IL-15 pathway. Proc. Natl. Acad. Sci. USA 98 (2001) 7970-7975
3. Battista S., Fidanza V., Fedele M., Klein-Szanto A.J., Outwater E., Brunner H., Santoro M., Croce C.M., and Fusco A. The expression of a truncated HMGI-C gene induces gigantism associated with lipomatosis. Cancer Res. 59 (1999) 4793-4797
4. Battista S., Fedele M., Martinez-Hoyos J., Pentimalli F., Pierantoni G.M., Visone R., De Martino I., Croce C.M., and Fusco A. High-mobility-group A1 (HMGA1) proteins down-regulate the expression of the recombination activating gene 2 (RAG2). Biochem. J. 389 (2005) 91-97
5. Bignon Y.J., Chen Y., Chang C.Y., Riley D.J., Windle J.J., Mellon P.L., and Lee W.H. Expression of a retinoblastoma transgene results in dwarf mice. Genes Dev. 7 (1993) 1654-1662
6. Cryns V.L., Alexander J.M., Kilbanski A., and Arnold A. The retinoblastoma gene in human pituitary tumors. J. Clin. Endocrinol. Metab. 77 (1993) 644-646
7. Fedele M., Berlingieri M.T., Scala S., Chiariotti L., Viglietto G., Rippel V., Bullerdiek J., Santoro M., and Fusco A. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts. Oncogene 17 (1998) 413-418
8. Fedele M., Battista S., Manfioletti G., Croce C.M., Giancotti V., and Fusco A. Role of the high mobility group A proteins in human lipomas. Carcinogenesis 22 (2001) 1583-1591
9. Fedele M., Battista S., Kenyon L., Baldassarre G., Fidanza V., Klein-Szanto A.J., Parlow A.F., Visone R., Pierantoni G.M., Outwater E., et al. Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene 21 (2002) 3190-3198
10. Field S.J., Tsai F.Y., Kuo F., Zubiaga A.M., Kaelin Jr. W.G., Livingston D.M., Orkin S.H., and Greenberg M.E. E2F-1 functions in mice to promote apoptosis and suppress proliferation. Cell 85 (1996) 549-561
11. Finelli P., Pierantoni G.M., Giardino D., Losa M., Rodeschini O., Fedele M., Valtorta E., Mortini P., Croce C.M., Larizza L., et al. The High Mobility Group A2 gene is amplified and overexpressed in human prolactinomas. Cancer Res. 62 (2002) 2398-2405
12. Franklin D.S., Godfrey V.L., Lee H., Kovalev G.I., Schoonhoven R., Chen-Kiang S., Su L., and Xiong Y. CDK inhibitors p18(INK4c) and p27(Kip1) mediate two separate pathways to collaboratively suppress pituitary tumorigenesis. Genes Dev. 12 (1998) 2899-2911
13. Hateboer G., Wobst A., Petersen B.O., Le Cam L., Vigo E., Sardet C., and Helin K. Cell cycle-regulated expression of mammalian CDC6 is dependent on E2F. Mol. Cell. Biol. 18 (1998) 6679-6697
14. Helin K., and Harlow E. Heterodimerization of the transcription factors E2F-1 and DP-1 is required for efficient binding to the adenovirus E4 (ORF6/7) protein. J. Virol. 68 (1994) 5027-5035
15. Helin K., Wu C.-L., Fattaey A.R., Lees J.A., Dynlacht B.D., Ngwu C., and Harlow E. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative transactivation. Genes Dev. 7 (1993) 1850-1861
16. Hu Q.J., Dyson N., and Harlow E. The regions of the retinoblastoma protein needed for binding to adenovirus E1A or SV40 large T antigen are common sites for mutations. EMBO J. 9 (1990) 1147-1155
17. Jacks T., Fazeli A., Schmitt E.M., Bronson R.T., Goodell M.A., and Weinberg R.A. Effects of an PRB mutation in the mouse. Nature 359 (1992) 295-300
18. Magnaghi-Jaulin L., Groisman R., Naguibneva I., Robin P., Lorain S., Le Villain J.P., Troalen F., Trouche D., and Harel-Bellan A. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391 (1998) 601-605
19. Martinez-Balbas M.A., Bauer U.M., Nielsen S.J., Brehm A., and Kouzarides T. Regulation of E2F1 activity by acetylation. EMBO J. 19 (2000) 662-671
20. Pierantoni G.M., Fedele M., Pentimalli F., Benvenuto G., Pero R., Viglietto G., Santoro M., Chiariotti L., and Fusco A. High mobility group I (Y) proteins bind HIPK2, a serine-threonine kinase protein which inhibits cell growth. Oncogene 20 (2001) 6132-6141
21. Putzer B.M., Rumpf H., Rega S., Brockmann D., and Esche H. E1A 12S and 13S of the transformation-defective adenovirus type 12 strain CS-1 inactivate proteins of the PRB family, permitting transactivation of the E2F-dependent promoter. J. Virol. 71 (1997) 9538-9548
22. Seville L.L., Shah N., Westwell A.D., and Chan W.C. Modulation of pRB/E2F functions in the regulation of cell cycle and in cancer. Curr. Cancer Drug Targets 5 (2005) 159-170
23. Shang Y., Hu X., DiRenzo J., Lazar M.A., and Brown M. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103 (2000) 843-852
24. Simpson D.J., Hibberts N.A., Mc Nicol A.M., Clayton R.N., and Farrell W.E. Loss of pPRB expression in pituitary adenomas is associated with metylation of the PRB1 CpG island. Cancer Res. 60 (2000) 1211-1216
25. Vigo E., Müller H., Prosperini E., Hateboer G., Cartwright P., Moroni M.C., and Helin K. CDC25A phosphatase is a target of E2F and is required for efficient E2F-1 induced S phase. Mol. Cell. Biol. 19 (1999) 6379-6395
26. Wood L.J., Maher J.F., Bunton T.E., and Resar L.M.S. The oncogenic properties of the HMG-I gene family. Cancer Res. 60 (2000) 4256-4261
27. Yamasaki L., Bronson R., Williams B.O., Dyson N.J., Harlow E., and Jacks T. Loss of E2F-1 reduces tumorigenesis and extends the lifespan of Rb1(+/-) mice. Nat. Genet. 18 (1998) 360-364